Factors contributing to nasal allergic late phase eosinophilia

American Journal of Otolaryngology - Head and Neck Medicine and Surgery

Volumn 27, Issue 3, 2006, Pages 190-199

  Kramer, Matthias F ^a   Jordan, Thorsten R ^a   Klemens, Christine ^a   Hilgert, Eva ^a   Hempel, John M ^a   Pfrogner, Elisabeth ^a   Rasp, Gerd ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; EOTAXIN; INTERLEUKIN 5; INTERLEUKIN 8; LEUKOTRIENE C4; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ALLERGY; ARTICLE; CLINICAL ARTICLE; DATA ANALYSIS; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHILIA; FEMALE; HUMAN; KINETICS; MALE; NOSE ALLERGY; NOSE SECRETION; PRIORITY JOURNAL; RHINOMETRY; TH2 CELL;

ADULT; ALLERGENS; CHEMOKINES, CC; EOSINOPHILIA; FEMALE; HUMANS; INTERLEUKIN-5; INTERLEUKIN-8; LEUKOTRIENE C4; MALE; MONOCYTE CHEMOATTRACTANT PROTEINS; NASAL MUCOSA; NASAL PROVOCATION TESTS; RHINITIS, ALLERGIC, SEASONAL; RHINOMETRY, ACOUSTIC; RISK FACTORS; STATISTICS, NONPARAMETRIC; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33646089197     PISSN: 01960709     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjoto.2005.09.013     Document Type: Article

References (76)

1. Motojima S., Akutsu I., Fukuda T., et al. Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma. Allergy 48 (1993) 98-106
2. Sur S., Gleich G.J., Swanson M.C., et al. Eosinophilic inflammation is associated with elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma. J Allergy Clin Immunol 96 (1995) 661-668
3. Kramer M.F., and Rasp G. Nasal polyposis: eosinophils and interleukin-5. Allergy 54 (1999) 669-680
4. Grevers G., and Stammberger H. Sinusitis und polyposis nasi. In: Grevers G. (Ed). Praktische Rhinologie (1998), Urban und Schwarzenberg, München Wien Baltimore 137-152
5. Danzig M., and Cuss F. Inhibition of interleukin-5 with a monoclonal antibody attenuates allergic inflammation. Allergy 52 (1997) 787-794
6. Appenroth E., Gunkel A.R., Muller H., et al. Activated and non-activated eosinophils in patients with chronic rhinosinusitis. Acta Otolaryngol Stockh 118 (1998) 240-242
7. Jankowski R. Eosinophils in the pathophysiology of nasal polyposis. Acta Otolaryngol Stockh 116 (1996) 160-163
8. Klimek L., and Rasp G. Norm values for eosinophil cationic protein in nasal secretions: influence of specimen collection. Clin Exp Allergy 29 (1999) 367-374
9. Kramer M.F., Pfrogner E., Ostertag P., et al. Nasal IL-16 and MIP-1 alpha in late phase allergic response. Allergy Asthma Proc 22 (2001) 127-132
10. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 38 (2002) 881-885
11. Sallusto F., Mackay C.R., and Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science 277 (1997) 2005-2007
12. Fujisawa T., Kato Y., Nagase H., et al. Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol 106 (2000) 507-513
13. Braun R.K., Franchini M., Erard F., et al. Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore. Eur J Immunol 23 (1993) 956-960
14. Smith W.B., Gamble J.R., Clark-Lewis I., et al. Interleukin-8 induces neutrophil transendothelial migration. Immunology 72 (1991) 65-72
15. Sehmi R., Cromwell O., Wardlaw A.J., et al. Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clin Exp Allergy 23 (1993) 1027-1036
16. Bischoff S.C., Brunner T., De Weck A.L., et al. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med 172 (1990) 1577-1582
17. Kuna P., Lazarovich M., and Kaplan A.P. Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol 97 (1996) 104-112
18. Kuna P., Reddigari S.R., Rucinski D., et al. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med 175 (1992) 489-493
19. Garcia-Zepeda E.A., Rothenberg M.E., Ownbey R.T., et al. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med 2 (1996) 449-456
20. Walker C., Virchow J.C., Brunijnzeel P.L., et al. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol 146 (1991) 1829-1835
21. Collins P.D., Marleau S., Griffiths-Johnson D.A., et al. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 182 (1995) 1169-1174
22. Mould A.W., Matthaei K.I., Young I.G., et al. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 99 (1997) 1064-1071
23. Ohashi Y., Nakai Y., Tanaka A., et al. Soluble vascular cell adhesion molecule-1 in perennial allergic rhinitis. Acta Otolaryngol 118 (1998) 105-109
24. Bochner B.S., Klunk D.A., Sterbinsky S.A., et al. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 154 (1995) 799-803
25. Schleimer R.P., Sterbinsky S.A., Kaiser J., et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 148 (1992) 1086-1092
26. Henderson W.R.J., Lewis D.B., Albert R.K., et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med 184 (1996) 1483-1494
27. Marom Z., Shelhamer J.H., Bach M.K., et al. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis 126 (1982) 449-451
28. Riechelmann H., Deutschle T., Friemel E., et al. Biological markers in nasal secretions. Eur Respir J 21 (2003) 600-605
29. Kramer M.F., Ostertag P., Pfrogner E., et al. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis. Laryngoscope 110 (2000) 1056-1062
30. Kramer M.F., Burow G., Pfrogner E., et al. In-vitro diagnosis of chronic nasal inflammation. Clin Exp Allergy 34 (2004) 1086-1092
31. Raphael G.D., Meredith S.D., Baraniuk J.N., et al. The pathophysiology of rhinitis II. Assessment of the sources of protein in histamine-induced nasal secretions. Am Rev Respir Dis 139 (1989) 791-800
32. Rasp G. Acoustic rhinometry: measuring the early and late phase of allergic immediate reaction in allergic rhinitis. Laryngorhinootologie 72 (1993) 125-130
33. Wang D., and Clement P. Assessment of early- and late-phase nasal obstruction in atopic patients after nasal allergen challenge. Clin Otolaryngol 20 (1995) 368-373
34. Pelikan Z. Late and delayed responses of the nasal mucosa to allergen challenge. Ann Allergy 41 (1978) 37-47
35. Schumacher M.J., and Pain M.C. Nasal challenge testing in grass pollen hay fever. J Allergy Clin Immunol 64 (1979) 202-208
36. Richerson H.B., Rajtora D.W., Penick G.D., et al. Cutaneous and nasal allergic responses in ragweed hay fever: lack of clinical and histopathologic correlations with late phase reactions. J Allergy Clin Immunol 64 (1979) 67-77
37. Dvoracek J.E., Yunginger J.W., Kern E.B., et al. Induction of nasal late-phase reactions by insufflation of ragweed-pollen extract. J Allergy Clin Immunol 73 (1984) 363-368
38. Eccles R., Reilly M., and Eccles K.S. Changes in the amplitude of the nasal cycle associated with symptoms of acute upper respiratory tract infection. Acta Otolaryngol 116 (1996) 77-81
39. Eccles R.B. The nasal cycle in respiratory defence. Acta Otorhinolaryngol Belg 54 (2000) 281-286
40. Lund V.J. Nasal physiology: neurochemical receptors, nasal cycle, and ciliary action. Allergy Asthma Proc 17 (1996) 179-184
41. Sanico A.M., Koliatsos V.E., Stanisz A.M., et al. Neural hyperresponsiveness and nerve growth factor in allergic rhinitis. Int Arch Allergy Immunol 118 (1999) 154-158
42. Togias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol 105 (2000) S599-S604
43. Mullol J., Raphael G.D., Lundgren J.D., et al. Comparison of human nasal mucosal secretion in vivo and in vitro. J Allergy Clin Immunol 89 (1992) 584-592
44. Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145-173
45. Greenfeder S., Umland S.P., Cuss F.M., et al. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir Res 2 (2001) 71-79
46. Simon H.U., Yousefi S., Weber M., et al. Human peripheral blood eosinophils express and release interleukin-8. Int Arch Allergy Immunol 107 (1995) 124-126
47. Humbles A.A., Conroy D.M., Marleau S., et al. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med 186 (1997) 601-612
48. Dubucquoi S., Desreumaux P., Janin A., et al. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med 179 (1994) 703-708
49. Howarth P.H. Leukotrienes in rhinitis. Am J Respir Crit Care Med 161 (2000) S133-S136
50. Kenney J.S., Baker C., Welch M.R., et al. Synthesis of interleukin-1 alpha, interleukin-6, and interleukin-8 by cultured human nasal epithelial cells. J Allergy Clin Immunol 93 (1994) 1060-1070
51. Ohkubo K., Ikeda K., Pawankar R., et al. Mechanisms of IL-6, IL-8, and GM-CSF release in nasal secretions of allergic patients after nasal challenge. Rhinology 36 (1998) 156-161
52. Rhyoo C., Sanders S.P., Leopold D.A., et al. Sinus mucosal IL-8 gene expression in chronic rhinosinusitis. J Allergy Clin Immunol 103 (1999) 395-400
53. Moller A., Lippert U., Lessmann D., et al. Human mast cells produce IL-8. J Immunol 151 (1993) 3261-3266
54. Teran L.M., Carroll M., Frew A.J., et al. Neutrophil influx and interleukin-8 release after segmental allergen or saline challenge in asthmatics. Int Arch Allergy Immunol 107 (1995) 374-375
55. Douglass J.A., Dhami D., Gurr C.E., et al. Influence of interleukin-8 challenge in the nasal mucosa in atopic and nonatopic subjects. Am J Respir Crit Care Med 150 (1994) 1108-1113
56. Schweizer R.C., Welmers B.A., Raaijmakers J.A., et al. RANTES- and interleukin-8-induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood 83 (1994) 3697-3704
57. Christodoulopoulos P., Wright E., Frenkiel S., et al. Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: effect of topical corticosteroids. J Allergy Clin Immunol 103 (1999) 1036-1044
58. Bischoff S.C., Krieger M., Brunner T., et al. Monocyte chemotactic protein 1 is a potent activator of human basophils. J Exp Med 175 (1992) 1271-1275
59. Gu L., Tseng S., Horner R.M., et al. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404 (2000) 407-411
60. Rollins B.J., and Pober J.S. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am J Pathol 138 (1991) 1315-1319
61. Van Coillie E., Van Damme J., and Opdenakker G. The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev 10 (1999) 61-86
62. Weber M., Uguccioni M., Ochensberger B., et al. Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J Immunol 154 (1995) 4166-4172
63. Polentarutti N., Introna M., Sozzani S., et al. Expression of monocyte chemotactic protein-3 in human monocytes and endothelial cells. Eur Cytokine Netw 8 (1997) 271-274
64. Yamada H., Yamaguchi M., Yamamoto K., et al. Eotaxin in induced sputum of asthmatics: relationship with eosinophils and eosinophil cationic protein in sputum. Allergy 55 (2000) 392-397
65. Kitayama J., Mackay C.R., Ponath P.D., et al. The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow. J Clin Invest 101 (1998) 2017-2024
66. Tachimoto H., Burdick M.M., Hudson S.A., et al. CCR3-active chemokines promote rapid detachment of eosinophils from VCAM-1 in vitro. J Immunol 165 (2000) 2748-2754
67. Zangrilli J.G., Shaver J.R., Cirelli R.A., et al. sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response. Am J Respir Crit Care Med 151 (1995) 1346-1353
68. Meng H., Tonnesen M.G., Marchese M.J., et al. Mast cells are potent regulators of endothelial cell adhesion molecule ICAM-1 and VCAM-1 expression. J Cell Physiol 165 (1995) 40-53
69. Pawankar R., Yamagishi S., and Yagi T. Revisiting the roles of mast cells in allergic rhinitis and its relation to local IgE synthesis. Am J Rhinol 14 (2000) 309-317
70. Baraniuk J.N. Pathogenesis of allergic rhinitis. J Allergy Clin Immunol 99 (1997) S763-S772
71. Drazen J.M., Austen K.F., Lewis R.A., et al. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci U S A 77 (1980) 4354-4358
72. Underwood D.C., Osborn R.R., Newsholme S.J., et al. Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. Am J Respir Crit Care Med 154 (1996) 850-857
73. Busse W.W. Leukotrienes and inflammation. Am J Respir Crit Care Med 157 (1998) S210-S213
74. Sedgwick J.B., Calhoun W.J., Gleich G.J., et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 144 (1991) 1274-1281
75. Wang D., and Clement P. Pathogenic mechanisms underlying the clinical symptoms of allergic rhinitis. Am J Rhinol 14 (2000) 325-333
76. Wang D., Smitz J., Waterschoot S., et al. An approach to the understanding of nasal early-phase reaction induced by nasal allergen challenge. Allergy 52 (1997) 162-167